Overall verdict
Neutral
5.8/10
1-year performance
+13.38%
Score breakdown
Up 13.4% over 1 year, 94% of the 52-week range.
Strongest: Profitability 9.2/10. Weakest: Valuation 3.0/10.
25 analysts, target +0.0% vs the price.
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands ; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands ;
and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. It also provides blades, razors, shave products, appliances, and other grooming products under the Braun, Gillette, and Venus brands. In addition, the company offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brands ; and gastrointestinal, pain relief, rapid diagnostics, respiratory, vitamins/minerals/supplements, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands.
Further, it provides fabric enhancers, and laundry additives and detergents under the Ariel, Downy, Gain, and Tide brands; and air and dish care, P&G professional, and surface care under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. Additionally, the company offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and menstrual care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands.
It sells its products through mass merchandisers, social ecommerce channels, grocery and specialty beauty stores, membership club stores, drug and department stores, distributors, wholesalers, airport duty-free and high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The company was founded in 1837 and is headquartered in Cincinnati, Ohio.
Sector
Consumer Staples
Industry
Household Products
Primary listing
Nyse
United States
CEO
Shailesh Jejurikar
Founded
1837
Employees
104 000
Revenue / employee
836 846 USD
Next earnings
January 20, 2027 (estimated)
Institutional holders
- GEODE CAPITAL MANAGEMENT, LLC2.94%
- FMR LLC1.30%
- Bank of New York Mellon Corp0.64%
- Rest of the register95.12%
3 13F filings as of September 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
170.52 USD
52-week low
137.62 USD
1-year performance
13.38%
Rising
Year-to-date performance
17.68%
Rising
Drawdown
-1.24%
Near its high
Position in the 52-week range
94% of range
Against the world ETF
Over 26 years, from December 2000 to October 2026, the share did not clearly beat the world ETF once risk is accounted for. It earned more, with as much risk: once that risk is counted, it did about as well as the ETF.
$10,000 placed at the end of December 2000 are worth today
| The Procter & Gamble | $82,522 |
| World ETF | $65,117 |
| S&P 500 | $91,204 |
| Risk-free placement | $15,894 |
The risk
- Shaking:the share moves about as much as the world ETF.
- Worst fall:-34 % between November 2007 and March 2009. $10,000 placed at the top fell to $6,560. The world ETF, at worst: -53 %. Back to its high in 26 months.
The Procter & Gamble earned more than the world ETF since 2000
Value of $10,000 placed at the end of December 2000, dividends reinvested, in dollars
- The Procter & Gamble: $82,522
- World ETF: $65,117
- S&P 500: $91,204
- Risk-free placement: $15,894
Based on past performance. This is not a recommendation.
Range: 151.00 USD - 154.76 USD (2 methods agree)
The price implies growth of 8.14% per year; the company grows at 3.79%.
Gross margin 50.5%, net margin 18.2%, ROIC 20.7%, ROE 29.6%.
Net margin
18.23%
Exceptional
Sector 8.27%|S&P 13.40%
Gross margin
50.48%
High
Return on equity (ROE)
29.58%
Exceptional
Sector 12.31%|S&P 17.06%
Return on invested capital (ROIC)
20.74%
Exceptional
Free cash flow margin (FCF)
17.45%
Exceptional
Profit-to-cash conversion (FCF conversion)
0.96x
High
Margin stability
4.3 pts
Steady
Revenue to net income
Growth
3.4/10Revenue up 4.0% over 1 year, 2.7% a year over 5, EPS 3.8% a year over 5.
Revenue (trailing 12 months)
87.9Md USD
Revenue growth (1y)
3.98%
Strong
Revenue growth (3y)
6.13%
Moderate
EPS growth (1y)
0.83%
Moderate
EPS CAGR (5y)
3.79%
Strong
EPS revisions (3 months)
-0.31%
Revised down
Valuation
3.0/10P/E 25.4x, forward P/E 24.6x, EV/EBITDA 17.5x, PEG 6.70. The multiple sits in the 46th percentile of its own 5-year history.
P/E (TTM)
25.4x
Expensive
Sector 18.9x|S&P 23.6x
Forward P/E
24.6x
Expensive
EV / EBITDA
17.5x
Expensive
Sector 10.3x|S&P 15.5x
PEG
6.70
Very expensive
Sector 2.28|S&P 0.91
Fair value (reverse DCF)
151.04 USD
Overvalued
P/E vs its own 5-year history
among the 46% lowest valuations
In line with its history
Market cap
390Md USD
Financial strength
8.5/10Cash covers 39.5% of the debt, net debt/EBITDA 1.0x.
Net debt / EBITDA
1.0x
Solid
Gearing (net debt / equity)
42.58%
Solid
Cash
15.4Md USD
Cash / market cap
3.94%
Tight
Cash / total debt
39.47%
Solid
Interest coverage
22.0x
Very solid
Net debt
23.6Md USD
Equity
55.3Md USD
Closed daily candles, 2 years
Last close on November 10, 2026: 168.66 USD
- MM20161.77
- MM50152.96
- MM200149.58
- RSI 1467.8
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+1.21%
200-day average slope, 3 months
+1.16%
50-day average slope, 1 month
+4.71%
Price structure
flat
Bullish RSI divergence
No
20-day volatility
1.82 % per day
Volatility change
+41.62%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2027 | 6.84 (6) | 6.97 (19) | 89 779 (18) | 24 512 (15) | 16 352 (5) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of November 10, 2026.
Same sub-industry: 36 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RKT | 6.5 | 6.6 | 47.5Md USD | 13.0x | 21.2 % | 0.3 % | 22.4 % | 1.7x | 4.3 % | -4.0 % | ||
| 2 | HEN3 | 6.1 | 6.1 | 36.8Md USD | 16.7x | 9.4 % | -5.1 % | 8.3 % | 0.2x | 6.3 % | 16.3 % | ||
| 3 | PG | 5.8 | 5.7 | 390Md USD | 25.4x | 18.2 % | 4.0 % | 20.7 % | 1.0x | 3.9 % | 13.4 % | ||
| 4 | KMB | 5.6 | 6.3 | 66.8Md USD | 11.0x | 10.5 % | -0.4 % | 21.0 % | 2.1x | 2.9 % | 5.3 % | ||
| 5 | 8113 | 5.6 | 4.9 | 12.5Md USD | 31.1x | 6.2 % | 5.3 % | 7.8 % | -1.9x | 5.0 % | 15.0 % | ||
| 6 | CHD | 5.4 | 5.2 | 26.4Md USD | 34.5x | 12.4 % | 1.0 % | 11.9 % | 1.5x | 4.0 % | 31.7 % | ||
| 7 | CLX | 5.3 | 5.1 | 12.9Md USD | 19.2x | 9.4 % | 33.3 % | 19.2 % | 4.8x | 3.5 % | 1.8 % | ||
| 8 | CL | 5.1 | 4.8 | 77.9Md USD | 38.3x | 9.6 % | 4.6 % | 26.3 % | 1.5x | 4.9 % | 24.4 % | ||
| 9 | ESSITY B | 5.1 | 5.5 | 19.7Md USD | 17.5x | 8.0 % | 4.1 % | 9.3 % | 1.1x | 6.0 % | 8.0 % |
